UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120
UBS analyst Michael Yee maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $80 to $120.
Share
Why It Matters
UBS, a big bank, still likes Kodiak Sciences and thinks it is worth more money. When smart experts raise their price targets, it means they see good things coming for the company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.